Krow Ampofo

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection
    Krow Ampofo
    Division of Pediatric Infectious Disease, University of Utah Health Sciences Center, 30 North 1900 E, Room 2A100, Salt Lake City, UT 84132, USA
    Pediatrics 118:2409-17. 2006
  2. doi request reprint Infectious disease issues in adoption of young children
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah 84108, USA
    Curr Opin Pediatr 25:78-87. 2013
  3. pmc The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatr Infect Dis J 31:228-34. 2012
  4. doi request reprint Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatr Infect Dis J 30:1100-3. 2011
  5. pmc Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Pediatr Infect Dis J 29:905-9. 2010
  6. doi request reprint Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection
    Krow Ampofo
    Division of Pediatric Infectious Disease, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Pediatrics 122:229-37. 2008
  7. pmc Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah
    Carrie L Byington
    Department of Pediatrics, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108, USA
    J Clin Microbiol 48:520-5. 2010
  8. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins
    Jeffery T Zobell
    Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, Utah 84113, USA
    Pediatr Pulmonol 48:107-22. 2013
  9. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary
    Jeffery T Zobell
    Department of Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, Utah, USA
    Pediatr Pulmonol 48:525-37. 2013
  10. pmc Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah
    Chris Stockmann
    Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatrics 132:421-8. 2013

Collaborators

Detail Information

Publications43

  1. ncbi request reprint Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection
    Krow Ampofo
    Division of Pediatric Infectious Disease, University of Utah Health Sciences Center, 30 North 1900 E, Room 2A100, Salt Lake City, UT 84132, USA
    Pediatrics 118:2409-17. 2006
    ..Influenza causes significant morbidity among children. Previous studies used indirect case ascertainment methods with little cost data. We sought to measure the burden of laboratory-confirmed influenza from hospitalized children...
  2. doi request reprint Infectious disease issues in adoption of young children
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah 84108, USA
    Curr Opin Pediatr 25:78-87. 2013
    ..To provide an update and overview of infectious disease issues in children of international adoption...
  3. pmc The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatr Infect Dis J 31:228-34. 2012
    ..We recognized an opportunity to describe the changes in epidemiology, clinical syndromes, and serotype distribution during a 14-year period including 4 years before vaccine introduction and spanning the entire PCV7 era...
  4. doi request reprint Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatr Infect Dis J 30:1100-3. 2011
    ..Despite decreases in PD among Utah children, complicated pneumonia/empyema has increased during the 7-valent pneumococcal conjugate vaccine era...
  5. pmc Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah
    Krow Ampofo
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Pediatr Infect Dis J 29:905-9. 2010
    ..We examined the relationship between circulating 2009 H1N1 and the occurrence of secondary bacterial parapneumonic empyema in children...
  6. doi request reprint Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection
    Krow Ampofo
    Division of Pediatric Infectious Disease, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Pediatrics 122:229-37. 2008
    ..Our objective was to demonstrate correlations between invasive pneumococcal disease in children and circulating respiratory viruses...
  7. pmc Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah
    Carrie L Byington
    Department of Pediatrics, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84108, USA
    J Clin Microbiol 48:520-5. 2010
    ..Serotype switch was not documented. Replacement disease with common ST of serotypes 1,3, 7F, and 19A rather than serotype switch was responsible for the increase in PPE in Utah children...
  8. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins
    Jeffery T Zobell
    Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, Utah 84113, USA
    Pediatr Pulmonol 48:107-22. 2013
    ..The usefulness of high dose piperacillin (>600 mg/kg/day) may be limited due to treatment-related adverse effects. Further understanding of these adverse effects in CF patients is needed...
  9. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive summary
    Jeffery T Zobell
    Department of Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, Utah, USA
    Pediatr Pulmonol 48:525-37. 2013
    ....
  10. pmc Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah
    Chris Stockmann
    Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Pediatrics 132:421-8. 2013
    ..However, cases continue to occur. It is unknown whether meningitis due to PCV7 and non-PCV7 serotypes causes similar morbidity and mortality...
  11. pmc Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7
    Liset Olarte
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Pediatrics 132:e17-24. 2013
    ..We evaluated the changes that occurred after PCV7 introduction among Utah infants aged 1 to 90 days, too young to be fully immunized...
  12. doi request reprint Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children
    Jeffrey M Bender
    Department of Pediatrics, Pediatric Infectious Diseases, University of Utah, Salt Lake City, Utah, USA
    Pediatr Infect Dis J 29:712-6. 2010
    ..Few studies examine the Streptococcus pneumoniae serotypes associated with HUS. Our objective was to describe the epidemiology of S. pneumoniae-related HUS (SP-HUS) and the serotypes associated with HUS in Utah children...
  13. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones
    Chris Stockmann
    Division of Pediatric Infectious Disease, University of Utah, Salt Lake City, UT 84108, USA
    Pediatr Pulmonol 48:211-20. 2013
    ..Further study is needed to determine the tolerability and efficacy of levofloxacin in APE. At this time, the routine use of levofloxacin in the treatment of APE in pediatric and adult patients cannot be recommended...
  14. pmc Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010
    Chris Stockmann
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, 84108, USA
    Clin Infect Dis 55:479-87. 2012
    ..Invasive group A Streptococcus (GAS) infections are associated with substantial morbidity and mortality. Recent national surveillance data report stable rates of invasive GAS disease, although these may not capture geographic variation...
  15. pmc Pneumococcal necrotizing pneumonia in Utah: does serotype matter?
    Jeffrey M Bender
    Department of Pediatrics, Division of Infectious Diseases, University of Utah, USA
    Clin Infect Dis 46:1346-52. 2008
    ..Our objectives were to describe temporal trends in PNP and to evaluate pneumococcal serotypes associated with PNP in Utah...
  16. pmc Seasonality of acute otitis media and the role of respiratory viral activity in children
    Chris Stockmann
    Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Pediatr Infect Dis J 32:314-9. 2013
    ..AOM and respiratory viruses both display seasonal variation. Our objective was to examine the temporal association between circulating respiratory viruses and the occurrence of pediatric ambulatory care visits for AOM...
  17. ncbi request reprint Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema
    Carrie L Byington
    Department of Pediatrics, University of Utah, Salt Lake City, USA
    Pediatr Infect Dis J 25:250-4. 2006
    ..Our objective was to describe the temporal trends in PPE in Utah before and after the availability of the 7-valent pneumococcal conjugate vaccine (PCV-7)...
  18. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium
    David C Young
    University of Utah College of Pharmacy, Salt Lake City, Utah 84112, USA
    Pediatr Pulmonol 48:1-7. 2013
    ..thrice-daily) and its impact on resistance and clinical efficacy. Further study is needed to determine the tolerability and efficacy of extended-interval dosing of CMS in the treatment of APE...
  19. doi request reprint Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients
    Jeffery T Zobell
    Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, Utah, USA
    Clin Ther 33:1844-50. 2011
    ..This dosing strategy is higher than the Food and Drug Administration (FDA)-approved package labeling. We evaluated the microbiologic efficacy of this dosing regimen...
  20. doi request reprint Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era
    Brian A Kendall
    Department of Medicine, University of Utah, Salt Lake City, UT, United States
    Vaccine 29:9123-6. 2011
    ..Adult and pediatric IPD serotypes are closely associated in Utah. PCV13 vaccination in Utah children is likely to significantly impact IPD in Utah adults...
  21. doi request reprint Influenza virus infection in infants less than three months of age
    Jeffrey M Bender
    University of Utah School of Medicine, Department of Pediatrics, Division of Pediatric Infectious Diseases, PO Box 581289, Salt Lake City, UT, USA
    Pediatr Infect Dis J 29:6-9. 2010
    ..We evaluated the presentation, outcomes, and the risk of serious bacterial infection (SBI) in infants <3 months old with influenza virus infection...
  22. pmc Parapneumonic empyema deaths during past century, Utah
    Jeffrey M Bender
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Emerg Infect Dis 15:44-8. 2009
    ..Vaccine strategies and antimicrobial drug stockpiling to control empyema will be important as we prepare for the next influenza pandemic...
  23. pmc Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema
    Anne J Blaschke
    Department of Pediatrics, University of Utah, Salt, Lake City, UT, USA
    Pediatr Infect Dis J 30:289-94. 2011
    ..Epidemiologic study is complicated by the low frequency of positive cultures. We sought to describe the epidemiology of PPE in children using molecular analysis of pleural fluid...
  24. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and carbapenems
    Jeffery T Zobell
    Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, UT, USA
    Pediatr Pulmonol 47:1147-58. 2012
    ..The usefulness of imipenem-cilastatin may be limited due to the rapid development of resistance...
  25. doi request reprint Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis
    Catherine M T Sherwin
    Department of Paediatrics, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84108, USA
    J Pharmacokinet Pharmacodyn 41:71-9. 2014
    ..In simulations, once daily dosing was the only regimen to achieve the pharmacodynamic target for all subjects with MICs <2 μg/mL. ..
  26. doi request reprint Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides
    David C Young
    University of Utah College of Pharmacy, Salt Lake City, Utah Intermountain Cystic Fibrosis Adult Center, Salt Lake City, Utah
    Pediatr Pulmonol 48:1047-61. 2013
    ..aeruginosa resistance with once-daily administration of tobramycin...
  27. doi request reprint Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis
    Chris Stockmann
    Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, Utah
    Pharmacotherapy 33:1288-96. 2013
    ..However, no studies have characterized the pharmacokinetic profile of vancomycin among pediatric cystic fibrosis patients...
  28. pmc Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov
    Chris Stockmann
    Department of Paediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA
    Int J Antimicrob Agents 42:161-6. 2013
    ..Leveraging the application of these data to guide the careful selection of antimicrobial agents will be essential to preserve their utility for years to come. ..
  29. doi request reprint A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients
    Jeffery T Zobell
    Department of Pharmacy, Intermountain Primary Children s Medical Center, Salt Lake City, UT 84113, USA
    Pediatr Pulmonol 46:987-90. 2011
    ..While this is of concern, it is not known if optimization of dosing strategies according to guidelines recommendations will result in clinical benefit...
  30. ncbi request reprint Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing
    Anne J Blaschke
    Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT, USA
    Clin Infect Dis 45:483-6. 2007
    ....
  31. doi request reprint Development and validation of a risk score for predicting hospitalization in children with influenza virus infection
    Jeffrey M Bender
    Department of Pediatrics, Division of Pediatric Infectious Disease, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Pediatr Emerg Care 25:369-75. 2009
    ..Many children with influenza seek care in emergency settings during seasonal influenza epidemics. We hypothesized that certain features could predict the need for hospitalization in children with influenza...
  32. doi request reprint Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses
    Carrie L Byington
    Department of Pediatrics, University of Utah, Salt Lake City, UT 84132, USA
    Clin Infect Dis 47:e4-6. 2008
    ..Clinicians must recognize the cutaneous manifestations of tularemia and be able to distinguish these from lesions seen with herpes viruses...
  33. doi request reprint Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic
    Adam L Hersh
    Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT, USA
    Pediatr Infect Dis J 30:895-7. 2011
    ..This increased sharply to 84% during the 2009 H1N1 period, indicating a favorable response by physicians to clinical guidelines...
  34. pmc Management of parapneumonic empyema
    Krow Ampofo
    Division of Pediatric Infectious Disease, University of Utah School of Medicine, Salt Lake City, Utah, USA
    Pediatr Infect Dis J 26:445-6. 2007
  35. doi request reprint Coccidioides immitis meningitis in a patient with hyperimmunoglobulin E syndrome due to a novel mutation in signal transducer and activator of transcription
    Annie E Powers
    Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Pediatr Infect Dis J 28:664-6. 2009
    ..We report the first case of Coccidioides immitis meningitis in a patient with HIES. Coccidioides should be included in the differential diagnosis for central nervous system infections in HIES patients...
  36. doi request reprint High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients
    Jeffery T Zobell
    Pharmacy, Intermountain Primary Children s Medical Center, 100 North Mario Capecchi Drive, Salt Lake City, UT 84113, USA
    J Cyst Fibros 9:280-3. 2010
    ..This dosing strategy is higher than the Cystic Fibrosis Foundation (CFF) recommendations and the Food and Drug Administration (FDA) approved package labeling. The purpose is to determine the safety of this dosing regimen...
  37. doi request reprint Bartonella vinsonii endocarditis in an adolescent with congenital heart disease
    Liset Olarte
    Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA
    Pediatr Infect Dis J 31:531-4. 2012
    ..berkhoffii endocarditis in a 19-year-old male with congenital heart disease. Diagnosis was established by Bartonella antibodies detected by immunofluorescence, and polymerase chain reaction amplification and sequencing from blood...
  38. doi request reprint Family clusters of variant X-linked chronic granulomatous disease
    Jeffrey M Bender
    Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA
    Pediatr Infect Dis J 28:529-33. 2009
    ..A high index of suspicion in the setting of unusual infections such as Burkholderia cepacia pneumonia is essential to make the diagnosis. Family screening can lead to early intervention, prophylaxis, and appropriate genetic counseling...
  39. doi request reprint Mollicute infections in neonates
    Rosemary C She
    Department of Pathology, University of Utah, Salt Lake City, UT, USA
    Pediatr Infect Dis J 28:248-50. 2009
    ..When mollicute infection is suspected, clinicians should alert laboratories, which will optimize methods of detection...
  40. pmc Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
    David W Kimberlin
    Department of Pediatrics, University of Alabama at Birmingham, AL 35233, USA
    J Infect Dis 207:709-20. 2013
    ..Children <2 years of age are at high risk of influenza-related mortality and morbidity. However, the appropriate dose of oseltamivir for children <2 years of age is unknown...
  41. doi request reprint Congenital cytomegalovirus infection: progressive postnatal chorioretinitis
    Jacob W Brubaker
    University of Utah, Salt Lake City, Utah, USA
    J Pediatr Ophthalmol Strabismus 46:249-51. 2009
    ..Optimal treatment of this disease is not well established. The authors describe an infant who had congenital cytomegalovirus infection with postnatal progression of chorioretinitis and required an extended course of ganciclovir therapy...
  42. doi request reprint Heightened neurologic complications in children with pandemic H1N1 influenza
    Jeffrey J Ekstrand
    Division of Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, UT 84108, USA
    Ann Neurol 68:762-6. 2010
    ..In addition, we noted a trend toward heightened neurological complications following second wave influenza activity...
  43. ncbi request reprint Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis
    Philip L Graham
    Departments of Pediatrics and Epidemiology, Columbia, University, New York, NY 10032, USA
    Pediatr Infect Dis J 21:798-800. 2002
    ..The patient tolerated the therapy without adverse effects...